SOMERVILLE, Mass., March 28, 2025--bluebird bio, Inc. (NASDAQ: BLUE) ("bluebird") today confirmed it has received an unsolicited non-binding written proposal (the "Ayrmid Proposal") from Ayrmid Ltd ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback